/Investor DB

2050 Capital — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Blackrock Neurotechblackrockneurotech.comin𝕏May 2021 · $10M

Blackrock Neurotech develops a neurotechnology platform, including brain-computer interface systems, aimed at improving patient lives and treating neurological conditions.

BiotechDeep TechMedical Devices

Florian Solzbacher(Co-Founder & CSO)inMarcus Gerhardt(Co-Founder & CEO)inThomas Thiele(CFO)in

BoardChristian Angermayer(Co-Chairman)Tim Sievers(Co-Chairman)

PartnerCornel Chiriac· solo GP

Co-investorsCatalio Capital Management, LPForepont Capital PartnersPresight CapitalTether

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.